Roivant Sciences Ltd [NASDAQ: ROIV] gained 7283804% on the last trading session, reaching $6410000.0 price per share at the time.
Roivant Sciences Ltd represents 695.94 million in outstanding shares, while the company has a total market value of $7.84 billion with the latest information. ROIV stock price has been found in the range of $11.4646 to $11.815.
If compared to the average trading volume of 6.41M shares, ROIV reached a trading volume of 7283804 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Roivant Sciences Ltd [ROIV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $16.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.18. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 15, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on January 05, 2024, representing the official price target for Roivant Sciences Ltd stock. Previously, the target price had yet another raise to $14, while Deutsche Bank analysts kept a Buy rating on ROIV stock.
The Price to Book ratio for the last quarter was 1.71, with the Price to Cash per share for the same quarter was set at 7.19.
Trading performance analysis for ROIV stock
Roivant Sciences Ltd [ROIV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.15. With this latest performance, ROIV shares gained by 5.48% in over the last four-week period, additionally sinking by -1.28% over the last 6 months – not to mention a drop of -2.45% in the past year of trading.
Roivant Sciences Ltd [ROIV]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Roivant Sciences Ltd [ROIV] shares currently have an operating margin of -1485.18% and a Gross Margin at 96.95%. Roivant Sciences Ltd’s Net Margin is presently recorded at -225.71%.
Return on Equity for this stock declined to -7.20%, with Return on Assets sitting at -7.20%.
An analysis of Institutional ownership at Roivant Sciences Ltd [ROIV]
There are presently around $83.50%, or 120.75% of ROIV stock, in the hands of institutional investors. The top three institutional holders of ROIV stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 71.36 million shares, which is approximately 9.6983%. VIKING GLOBAL INVESTORS LP, holding 69.16 million shares of the stock with an approximate value of $$730.98 million in ROIV stocks shares; and VIKING GLOBAL INVESTORS LP, currently with $$705.23 million in ROIV stock with ownership which is approximately 9.0674%.
